Fundraising Fox

Principia Biopharma

South San Francisco, US · Delaware corporation · 7 known investors

principiabio.com ↗
Biotech

Founders & leadership

MB
MARTIN BABLERExecutive

Board

PT
PETER THOMPSONBoard director
SA
SRINIVAS AKKARAJUBoard director
MDMICHAEL DYBBS
MICHAEL DYBBSin𝕏Board of Directors2014–2016Partner at Samsara BioCapital
SG
SIMEON GEORGEBoard director
LJ
LEWIS J. SHUSTERBoard director
NU
NASSIM USMANBoard director

Investors · 7

Access BiotechnologyNew York City
Mission BiocapitalSan Francisco · $500K
Sofinnova VenturesMenlo Park · $100K – $15M
Mission Bay CapitalreportedSan Francisco
New Leaf Venture PartnersreportedNew York
OrbiMedreportedNew York · $1M – $75M
Samsara BioCapitalreportedPalo Alto

Reported raises · per SEC filings

Form D private placements

$65.3M disclosed across 2 rounds · 2015–2018

▶$50MraisedSep 2018 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Simeon GeorgeDirector
  • Alan ColowickDirector
  • Srinivas AkkarajuDirector
  • Nassim UsmanDirector
  • Peter ThompsonDirector
  • Daniel BeckerDirector
  • Martin BablerExecutive Officer, Director
  • Lewis J. ShusterDirector
Offering amount
$50M
Amount sold
$50M
First sale
Aug 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.3MraisedAug 2015 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • MARTIN BABLERExecutive Officer, Director
  • PETER THOMPSONDirector
  • SRINIVAS AKKARAJUDirector
  • LEWIS J. SHUSTERDirector
  • MICHAEL DYBBSDirector
  • SIMEON GEORGEDirector
  • NASSIM USMANDirector
Offering amount
$15.3M
Amount sold
$15.3M
First sale
Jul 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Principia Biopharma Raises $50M in Series B Financing |FinSMEsfinsmes.com · Apr 2014Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Teamprnewswire.com · Oct 2012Buy Principia Biopharma Inc Stock – PRNB Stock Quote Today & Investment Insights - Public.compublic.com

Frequently asked questions

Who are Principia Biopharma's investors?
Principia Biopharma's investors include Access Biotechnology, Mission Biocapital, Sofinnova Ventures, Mission Bay Capital, New Leaf Venture Partners, OrbiMed, Samsara BioCapital.
How much funding has Principia Biopharma raised?
Principia Biopharma has disclosed $65.3M raised across 2 rounds.
Where is Principia Biopharma headquartered?
Principia Biopharma is headquartered in South San Francisco, US.